pharmaphorum2y
Merck defends blockbuster Januvia franchise from patent challenge
as well as metformin combinations Janumet and Janumet XR. The US patent (No. 7,326,708) was challenged by Mylan Pharma, now Viatris, before the US Patent and Trademark Office (USPTO), which ruled ...